We are live on ! Find out more
AONC

American Oncology Network, Inc. Class A Common Stock

Delisted

AONC was delisted on the 7th of June, 2024.

13 hedge funds and large institutions have $18.1M invested in American Oncology Network, Inc. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

84% less funds holding

Funds holding: 7913 (-66)

88% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 8

94% less capital invested

Capital invested by funds: $301M → $18.1M (-$283M)

96% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 69

Holders
13
Holders Change
-66
Holders Change %
-83.54%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
1
Reduced
8
Closed
69
Calls
$500K
Puts
Net Calls
+$500K
Net Calls Change
+$15K
Name Holding Trade Value Shares
Change
Change in
Stake
Calamos Advisors
26
Calamos Advisors
Illinois
-$6.28M -625,000 Closed
RCM
27
Radcliffe Capital Management
Pennsylvania
-$6.08M -605,146 Closed
WCMNY
28
Westchester Capital Management (New York)
New York
-$5.96M -593,690 Closed
DKCM
29
Davidson Kempner Capital Management
New York
-$5.52M -550,000 Closed
SC
30
Sculptor Capital
New York
-$5.49M -546,683 Closed
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
-$5.05M -502,099 Closed
SFM
32
Soros Fund Management
New York
-$5.02M -500,000 Closed
CF
33
Cantor Fitzgerald
New York
-$4.97M -495,000 Closed
AC
34
Aristeia Capital
Connecticut
-$4.27M -424,642 Closed
WP
35
Woodline Partners
California
-$1.08K -400,000 Closed
CSS
36
Cubist Systematic Strategies
Connecticut
-$3.99M -396,726 Closed
LP
37
LMR Partners
United Kingdom
-$3.53M -351,299 Closed
AMC
38
Atlas Merchant Capital
New York
-$3.26M -325,000 Closed
CL
39
CSS LLC
Illinois
-$2.65M -263,546 Closed
COPPSERS
40
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$2.51M -250,000 Closed
DCM
41
Dupont Capital Management
Delaware
-$2.51M -250,000 Closed
MMA
42
Mizuho Markets Americas
New York
-$2.43M -241,576 Closed
CC
43
Centiva Capital
New York
-$2.2M -218,904 Closed
PAMP
44
Polar Asset Management Partners
Ontario, Canada
-$2.14M -213,296 Closed
Capstone Investment Advisors
45
Capstone Investment Advisors
New York
-$2.01M -200,000 Closed
CCA
46
Castle Creek Arbitrage
Colorado
-$2.01M -200,000 Closed
PMAM
47
Picton Mahoney Asset Management
Ontario, Canada
-$2.01M -200,000 Closed
VI
48
Vestcor Inc
New Brunswick, Canada
-$2.01M -200,000 Closed
SFM
49
Spartan Fund Management
Canada
-$1.92M -191,063 Closed
RL
50
RPO LLC
Connecticut
-$1.9M -189,017 Closed

AONC Hedge Fund Activity: Q1 2023 in Review

13 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q1 2023, worth a combined $18.1M — down 94% from $301M a quarter earlier.

Sellers outnumbered buyers: 69 funds closed out of AONC and 3 opened new positions — a net loss of 66 holders — while 8 trimmed existing stakes and 1 added.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $1.48M. The largest seller was Marshall Wace, exiting entirely with an estimated $15.5M sold.

  • 13 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q1 2023, down from 79 in Q4 2022.
  • Funds reported $18.1M of American Oncology Network, Inc. Class A Common Stock stock for Q1 2023, down 94% quarter-over-quarter.
  • 3 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q1 2023 and 69 closed out, a net change of -66 holders.
  • The largest American Oncology Network, Inc. Class A Common Stock buyer in Q1 2023 was UBS O'Connor, an estimated $1.48M added.
  • The largest American Oncology Network, Inc. Class A Common Stock seller in Q1 2023 was Marshall Wace, an estimated $15.5M sold.

Based on aggregated 13F filings for Q1 2023.